(DIR) Return Create A Forum - Home --------------------------------------------------------- MS Speaks (HTM) https://msspeaks.createaforum.com --------------------------------------------------------- ***************************************************** (DIR) Return to: OCREVUS (ocrelizumab) ***************************************************** #Post#: 4464-------------------------------------------------- Subcutaneous Ocrevus gets EU approval By: agate Date: June 26, 2024, 12:57 am --------------------------------------------------------- From Morningstar (June 24, 2024)--"Roche's Multiple Sclerosis Injection Gets EU Approval": (HTM) https://www.morningstar.com/news/dow-jones/20240625262/roches-multiple-sclerosis-injection-gets-eu-approval And from European Pharmaceutical Review (June 25)--New multiple sclerosis treatment option granted in EU": (HTM) https://www.europeanpharmaceuticalreview.com/news/230766/new-multiple-sclerosis-treatment-option-granted-in-eu/ #Post#: 4483-------------------------------------------------- (The Guardian) MS patients in England offered 10-minute jab in p lace of infusions By: agate Date: July 13, 2024, 12:37 am --------------------------------------------------------- Looks as if the UK will be offering Ocrevus as 10-minute, hospital-administered injections. From The Guardian (July 12, 2024)--"MS patients in England offered 10-minute jab in place of infusions": (HTM) https://www.theguardian.com/society/article/2024/jul/12/multiple-sclerosis-england-10-minute-jab-ocrelizumab *****************************************************